Most Recent
A judge has approved the settlement of a class action brought on behalf of sovereign bondholders over the disclosure of climate change risks, despite a late scrap with the government over whether the deal puts a stop to future cases.
An Australian law firm is investigating a class action against drug manufacturers over a commonly prescribed antibiotic said to cause “disabling” side effects, including nerve damage and psychosis.
The ACCC has approved the buyout of Australian energy giant Origin Energy, after finding that significant competition concerns were outweighed by the likely benefits to the country's transition to renewable energy.
Westpac has been hit with a class action for allegedly overcharging superannuation customers for insurance coverage, months after paying $30 million to settle a separate superannuation class action.
A failed class action against Volkswagen over Takata airbags is seeking special leave from the High Court, arguing an appeals court was wrong to find a reasonable consumer would be comfortable with an airbag that posed a potential risk of rupture.
United Petroleum, which is facing a franchisee class action over allegedly loss-making Pie Face stores, is resisting a plaintiff law firm's bid for “a right of veto” over the petrol giant's communications with group members, even those not represented by the firm.
The corporate regulator has again initiated proceedings against Gold Coast-based BHF Solutions and Cigno for allegedly providing credit without a licence after the lenders failed to convince the Full Court that their services fell outside the scope of the Credit Act.
Pathology giant Australian Clinical Labs has proposed a divestiture of collection centres amid competition concerns about its proposed takeover of competitor Healius, the owner of Dorevitch Pathology.
The Australian Securities and Investments Commission has filed an appeal after a judge ordered ACBF Funeral Plans to pay $1.2 million for misleading its First Nations customers, less than one-fifth of what the regulator sought.
Livestock drug company Zoetis has agreed to accept a $2.1 million payout to cover its costs in successfully defending a class action dubbed "totally off the planet" by a judge.